deus semaglutide FDA Clears For Cardiac Risk Reduction in Diabetic Patients deus semaglutide Oral diabetes drug

Samples collection and preparation Samples were collected at 70 days post-experiment initiation

This metabolic improvement may explain why some patients experience blood pressure benefits even when weight loss is modest, suggesting pleiotropic mechanisms beyond simple caloric deficit

GLP-1 medications like semaglutide work by reducing appetite, slowing digestion, and helping your body regulate blood sugar

Preclinical studies in mice demonstrate that GLP-1RAs exhibit significant antitumor activity against endometrial cancer cells [40], and their ability to improve metabolism and body weight could offer preventive benefits for individuals at high risk of developing endometrial cancer [41]

Bioprocess Optimization for the Overproduction of Catalytic Domain of Ubiquitin-like Protease 1 (Ulp1) from S